{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:51:31Z","timestamp":1770511891090,"version":"3.49.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"William R. Hummel Homocystinuria Research Fund"},{"name":"Denver Children's Hospital"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.ymgme.2012.04.025","type":"journal-article","created":{"date-parts":[[2012,5,6]],"date-time":"2012-05-06T12:30:21Z","timestamp":1336307421000},"page":"55-65","source":"Crossref","is-referenced-by-count":16,"title":["Altered expression of apoA-I, apoA-IV and PON-1 activity in CBS deficient homocystinuria in the presence and absence of treatment: Possible implications for cardiovascular outcomes"],"prefix":"10.1016","volume":"107","author":[{"given":"Hua","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally P.","family":"Stabler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth N.","family":"Maclean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2012.04.025_bb0005","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"2007","article-title":"Disorders of transsulfuration","author":"Mudd","year":"2001"},{"key":"10.1016\/j.ymgme.2012.04.025_bb0010","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM198308253090802","article-title":"Homocystinuria\u2014the effects of betaine in the treatment of patients not responsive to pyridoxine","volume":"309","author":"Wilcken","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0015","first-page":"1","article-title":"The natural history of homocystinuria due to cystathionine b-synthase deficiency","volume":"37","author":"Mudd","year":"1985","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0020","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1073\/pnas.92.5.1585","article-title":"Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia","volume":"92","author":"Watanabe","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2010.06.007","article-title":"Cystathionine beta-synthase null homocystinuric mice fail to exhibit altered hemostasis or lowering of plasma homocysteine in response to betaine treatment","volume":"101","author":"Maclean","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ymgme.2010.06.010","article-title":"A novel transgenic mouse model of CBS-deficient homocystinuria does not incur hepatic steatosis or fibrosis and exhibits a hypercoagulative phenotype that is ameliorated by betaine treatment","volume":"101","author":"Maclean","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0355","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ymgme.2011.11.190","article-title":"Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk","volume":"105","author":"Maclean","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0040","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ymgme.2011.04.012","article-title":"Constitutive induction of pro-inflammatory and chemotactic cytokines in cystathionine beta-synthase deficient homocystinuria","volume":"103","author":"Keating","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00041433-199604000-00004","article-title":"Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins","volume":"7","author":"Mackness","year":"1996","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0050","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0037-1613648","article-title":"Mouse liver paraoxonase-1 gene expression is downregulated in hyperhomocysteinemia","volume":"92","author":"Janel","year":"2004","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0055","doi-asserted-by":"crossref","first-page":"36958","DOI":"10.1074\/jbc.M110.127829","article-title":"Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease","volume":"285","author":"Lewis","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0060","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.RES.0000204825.66410.0b","article-title":"Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease","volume":"98","author":"Mikael","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0065","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.RES.0000242559.42077.22","article-title":"Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance","volume":"99","author":"Liao","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0070","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.atherosclerosis.2010.04.028","article-title":"Cysteinemia, rather than homocysteinemia, is associated with plasma apolipoprotein A-I levels in hyperhomocysteinemia: lipid metabolism in cystathionine beta-synthase deficiency","volume":"212","author":"Nuno-Ayala","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ymgme.2012.04.025_bb0075","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0005-2760(81)90293-9","article-title":"Alterations of plasma HDL lipids and apolipoproteins in female rats treated with ethynyl estradiol","volume":"666","author":"Wilcox","year":"1981","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2012.04.025_bb0080","first-page":"521","volume":"18","author":"Bergmeyer","year":"1980","journal-title":"J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0085","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/0026-0495(93)90198-W","article-title":"Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism","volume":"42","author":"Allen","year":"1993","journal-title":"Metabolism"},{"key":"10.1016\/j.ymgme.2012.04.025_bb0090","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1373\/clinchem.2003.026252","article-title":"Quantification of serum and urinary s-adenosylmethionine and s-adenosylhomocysteine by stable-isotope-dilution liquid chromatography-mass spectrometry","volume":"50","author":"Stabler","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0095","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0090-9556(25)07065-5","article-title":"Purification of human serum paraoxonase\/arylesterase. Evidence for one esterase catalyzing both activities","volume":"19","author":"Gan","year":"1991","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0360","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2012.04.025_bb0110","doi-asserted-by":"crossref","first-page":"31504","DOI":"10.1074\/jbc.M213036200","article-title":"Altered gene expression in liver from a murine model of hyperhomocysteinemia","volume":"278","author":"Robert","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0115","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.ATV.21.4.473","article-title":"Paraoxonase and atherosclerosis","volume":"21","author":"Durrington","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0120","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/28406","article-title":"Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis","volume":"394","author":"Shih","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2012.04.025_bb0125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2012.04.025_bb0130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/pr.58.3.1","article-title":"Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis","volume":"58","author":"Kontush","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0135","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1194\/jlr.R400001-JLR200","article-title":"The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL","volume":"45","author":"Navab","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0140","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.plipres.2004.05.002","article-title":"Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins","volume":"43","author":"Saito","year":"2004","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0145","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.atherosclerosis.2006.07.017","article-title":"Common variants of apolipoprotein A-IV differ in their ability to inhibit low density lipoprotein oxidation","volume":"192","author":"Wong","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ymgme.2012.04.025_bb0150","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2217\/clp.10.37","article-title":"Apolipoproteins in the brain: implications for neurological and psychiatric disorders","volume":"51","author":"Elliott","year":"2010","journal-title":"Clin. Lipidol."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041433-200104000-00003","article-title":"Cholesterol metabolism in the brain","volume":"12","author":"Dietschy","year":"2001","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0160","first-page":"129","article-title":"Mild hyperhomocysteinemia and arterial occlusive disease","volume":"82","author":"Selhub","year":"1997","journal-title":"Haematologica"},{"key":"10.1016\/j.ymgme.2012.04.025_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V90.1.1","article-title":"Homocysteine and thrombotic disease","volume":"90","author":"D'Angelo","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2012.04.025_bb0170","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/01.ATV.0000107402.79771.fc","article-title":"Genetic determinants of arterial thrombosis","volume":"24","author":"Voetsch","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0175","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1172\/JCI118359","article-title":"Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein","volume":"96","author":"Watson","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0180","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI1649","article-title":"Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase","volume":"101","author":"Aviram","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0365","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1096\/fj.09-144410","article-title":"Paraoxonase 1 protects against protein N-homocysteinylation in humans","volume":"24","author":"Perla-Kajan","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0370","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-60761-350-3_11","article-title":"The role of paraoxonase 1 in the detoxification of homocysteine thiolactone","volume":"660","author":"Jakubowski","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0195","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhep.2005.12.018","article-title":"Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases","volume":"45","author":"Ferre","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0200","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/353265a0","article-title":"Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI","volume":"353","author":"Rubin","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2012.04.025_bb0205","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1161\/01.ATV.17.10.2158","article-title":"HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL","volume":"17","author":"Suc","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0210","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1161\/01.ATV.15.11.1987","article-title":"High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules","volume":"15","author":"Cockerill","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0215","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0022-2275(20)39788-1","article-title":"Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: stimulation by high density lipoprotein and other agents","volume":"21","author":"Ho","year":"1980","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0220","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1161\/CIRCULATIONAHA.106.649954","article-title":"High-density lipoprotein and the risk of recurrent venous thromboembolism","volume":"115","author":"Eichinger","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ymgme.2012.04.025_bb0225","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","article-title":"HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms","volume":"8","author":"Navab","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0230","doi-asserted-by":"crossref","first-page":"32336","DOI":"10.1074\/jbc.M109.047472","article-title":"The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor","volume":"284","author":"Tang","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0235","doi-asserted-by":"crossref","first-page":"M712","DOI":"10.1093\/gerona\/57.11.M712","article-title":"Plasma HDL levels highly correlate with cognitive function in exceptional longevity","volume":"57","author":"Atzmon","year":"2002","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0240","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1182\/blood.V97.8.2381","article-title":"Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes","volume":"97","author":"Hyka","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2012.04.025_bb0375","doi-asserted-by":"crossref","first-page":"13834","DOI":"10.1074\/jbc.M110.202275","article-title":"Tristetraprolin-dependent post-transcriptional regulation of inflammatory cytokine mRNA expression by apolipoprotein A-I: role of ATP-binding membrane cassette transporter A1 and signal transducer and activator of transcription 3","volume":"286","author":"Yin","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0250","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0022-2275(20)37227-8","article-title":"ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes","volume":"38","author":"Plump","year":"1997","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0255","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2004.08.039","article-title":"Very low density lipoproteins provide a vector for secretion of paraoxonase-1 from cells","volume":"179","author":"Deakin","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ymgme.2012.04.025_bb0260","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1096\/fj.02-0456fje","article-title":"Homocysteine-betaine interactions in a murine model of 5,10-methylenetetrahydrofolate reductase deficiency","volume":"17","author":"Schwahn","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0265","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jnutbio.2007.05.005","article-title":"Dietary methionine effects on plasma homocysteine and HDL metabolism in mice","volume":"19","author":"Velez-Carrasco","year":"2008","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0270","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/humu.10089","article-title":"High homocysteine and thrombosis without connective tissue disorders are associated with a novel class of cystathionine beta-synthase (CBS) mutations","volume":"19","author":"Maclean","year":"2002","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0275","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/hep.1840060628","article-title":"Apolipoprotein AI and alcoholic liver disease","volume":"6","author":"Poynard","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.ymgme.2012.04.025_bb0280","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.510230107","article-title":"Quantification of apolipoprotein A-I and B messenger RNA in heavy drinkers according to liver disease","volume":"23","author":"Mathurin","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.ymgme.2012.04.025_bb0285","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1021\/pr900593r","article-title":"An altered pattern of liver apolipoprotein A-I isoforms is implicated in male chronic hepatitis B progression","volume":"9","author":"Yang","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0380","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12072-011-9291-x","article-title":"Serum apolipoprotein C-III is independently associated with chronic hepatitis C infection and advanced fibrosis","volume":"6","author":"Rowell","year":"2012","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0295","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1054-3589(08)61001-7","article-title":"Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases","volume":"38","author":"Lieber","year":"1997","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0300","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.freeradbiomed.2005.04.011","article-title":"Effects of N-acetylcysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition","volume":"39","author":"Ronis","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0305","doi-asserted-by":"crossref","first-page":"G109","DOI":"10.1152\/ajpgi.00145.2010","article-title":"Effects of long-term ethanol administration in a rat total enteral nutrition model of alcoholic liver disease","volume":"300","author":"Ronis","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0310","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1549-8719.2010.00078.x","article-title":"Glycine and taurine equally prevent fatty livers from Kupffer cell-dependent injury: an in vivo microscopy study","volume":"18","author":"Bruns","year":"2011","journal-title":"Microcirculation"},{"key":"10.1016\/j.ymgme.2012.04.025_bb0315","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0022-2275(20)38532-1","article-title":"The apolipoprotein multigene family: biosynthesis, structure, structure-function relationships, and evolution","volume":"29","author":"Li","year":"1988","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0385","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1194\/jlr.M500240-JLR200","article-title":"Janus kinase 2 modulates the lipid-removing but not protein-stabilizing interactions of amphipathic helices with ABCA1","volume":"47","author":"Tang","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0325","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/01.CIR.0000070589.61860.A9","article-title":"L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease","volume":"107","author":"Ou","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ymgme.2012.04.025_bb0330","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1161\/01.RES.0000190634.60042.cb","article-title":"Effects of D-4F on vasodilation and vessel wall thickness in hypercholesterolemic LDL receptor-null and LDL receptor\/apolipoprotein A-I double-knockout mice on Western diet","volume":"97","author":"Ou","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0335","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/01.ATV.0000167412.98221.1a","article-title":"D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice","volume":"25","author":"Navab","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0340","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1161\/01.ATV.0000165694.39518.95","article-title":"Apolipoprotein A-I mimetic peptides","volume":"25","author":"Navab","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0345","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.nbd.2009.03.007","article-title":"Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease","volume":"34","author":"Handattu","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymgme.2012.04.025_bb0350","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1194\/jlr.M600214-JLR200","article-title":"D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet","volume":"47","author":"Buga","year":"2006","journal-title":"J. Lipid Res."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212001680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212001680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T09:00:35Z","timestamp":1743066035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719212001680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":70,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1096719212001680"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2012.04.025","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}